Biotech Hunter
Biotech Hunter
Home
Companies
Trials
People
Search
Clinical Trials Directory
Explore 21,535 clinical trials worldwide
Search
Showing 18201-18250 of 21,535 trials
Active filters:
Status: Active, not recruiting
Clinical Trials (21,535)
NCT02838316
Autologous Muscle Derived Cells for Gastro-Intestinal Repair (AMDC-GIR) for Tongue Dysphagia
PHASE1
Active, not recruiting
18 participants
Started: May 24, 2017 · Completed: Dec 31, 2026
1 condition
2 sponsors
1 location
NCT02862275
Atezolizumab in Treating Patients With Cancer Following Adoptive Cell Transfer
PHASE1
Active, not recruiting
40 participants
Started: May 24, 2017 · Completed: Nov 21, 2026
3 conditions
1 sponsor
9 locations
NCT03118492
Combination Chemotherapy, Total Body Irradiation, and Donor Blood Stem Cell Transplant in Treating Patients With Secondary Myelofibrosis
PHASE1
Active, not recruiting
22 participants
Started: May 24, 2017 · Completed: May 26, 2026
1 condition
2 sponsors
1 location
NCT03054519
Improve PAD PERformance With METformin
PHASE3
Active, not recruiting
203 participants
Started: May 23, 2017 · Completed: Nov 30, 2025
1 condition
1 sponsor
5 locations
NCT03138720
Pre-operative Treatment for Patients With Untreated Pancreatic Cancer
PHASE2
Active, not recruiting
24 participants
Started: May 23, 2017 · Completed: Aug 1, 2025
4 conditions
1 sponsor
1 location
NCT02589522
Testing the Safety of M6620 (VX-970) When Given With Standard Whole Brain Radiation Therapy for the Treatment of Brain Metastases From Non-small Cell Lung Cancer, Small Cell Lung Cancer, or Neuroendocrine Tumors
PHASE1
Active, not recruiting
15 participants
Started: May 22, 2017 · Completed: Sep 18, 2026
7 conditions
1 sponsor
9 locations
NCT03036007
Physiotherapy After Anterior Cervical Spine Surgery
NA
Active, not recruiting
20 participants
Started: May 22, 2017 · Completed: Jan 1, 2025
2 conditions
1 sponsor
1 location
NCT03085212
Strategies for Pregnancy Achievement
NA
Active, not recruiting
40 participants
Started: May 21, 2017 · Completed: Dec 31, 2026
4 conditions
3 sponsors
1 location
NCT03133923
Phase II of Live Attenuated Mumps (F-genotype) Vaccine (Human Diploid Cell, KMB-17) in Chinese Infants
PHASE2
Active, not recruiting
1,080 participants
Started: May 20, 2017 · Completed: Jul 1, 2024
1 condition
2 sponsors
1 location
NCT03146650
Nivolumab and Ipilimumab in Treating Patients With Metastatic/Recurrent ACC of All Sites and Non-ACC Salivary Gland Cancer
PHASE2
Active, not recruiting
25 participants
Started: May 19, 2017 · Completed: Aug 11, 2025
7 conditions
3 sponsors
1 location
NCT03491176
Magnetic Resonance (MR) Imaging & Blood Biomarkers for Head and Neck Cancer
N/A
Active, not recruiting
100 participants
Started: May 18, 2017 · Completed: Oct 31, 2025
3 conditions
2 sponsors
1 location
NCT02997020
Ivacaftor for Acquired CFTR Dysfunction in Chronic Rhinosinusitis (EDSPD Protocol)
N/A
Active, not recruiting
30 participants
Started: May 18, 2017 · Completed: Apr 30, 2026
1 condition
2 sponsors
1 location
NCT02867592
Cabozantinib-S-Malate in Treating Younger Patients With Recurrent, Refractory, or Newly Diagnosed Sarcomas, Wilms Tumor, or Other Rare Tumors
PHASE2
Active, not recruiting
109 participants
Started: May 18, 2017 · Completed: Jun 27, 2026
44 conditions
1 sponsor
142 locations
NCT03548792
Comparison of an Old Versus a New Total Knee Replacement
NA
Active, not recruiting
185 participants
Started: May 18, 2017 · Completed: Jul 5, 2029
1 condition
1 sponsor
1 location
NCT03164174
Atherosclerosis-Progression in Coronary Arteries Compared to Periphery Vessels
N/A
Active, not recruiting
64 participants
Started: May 17, 2017 · Completed: Jan 31, 2028
1 condition
1 sponsor
1 location
NCT03741920
Evaluation of the Personal KinetiGraph™ (PKG™) to Improve Insight Into Parkinson's Disease Status
NA
Active, not recruiting
231 participants
Started: May 17, 2017 · Completed: Oct 31, 2025
1 condition
1 sponsor
12 locations
NCT03225417
Ixazomib in the Prophylaxis of Chronic Graft-versus-host Disease.
PHASE1/PHASE2
Active, not recruiting
142 participants
Started: May 16, 2017 · Completed: Dec 31, 2024
2 conditions
2 sponsors
8 locations
NCT03639701
Treatment of TK2 Deficiency With Thymidine and Deoxycytidine
PHASE1/PHASE2
Active, not recruiting
23 participants
Started: May 16, 2017 · Completed: May 31, 2026
2 conditions
9 sponsors
1 location
NCT02845323
Neoadjuvant Nivolumab With and Without Urelumab in Cisplatin-Ineligible or Chemotherapy-refusing Patients With Muscle-Invasive Urothelial Carcinoma of the Bladder
PHASE2
Active, not recruiting
15 participants
Started: May 16, 2017 · Completed: Dec 31, 2026
2 conditions
2 sponsors
5 locations
NCT02627443
Carboplatin, Gemcitabine Hydrochloride, and Berzosertib in Treating Patients With Recurrent and Metastatic Ovarian, Primary Peritoneal, or Fallopian Tube Cancer
PHASE1
Active, not recruiting
35 participants
Started: May 16, 2017 · Completed: Jun 3, 2026
12 conditions
1 sponsor
14 locations
NCT03145181
Dose Escalation Study of Teclistamab, a Humanized BCMA*CD3 Bispecific Antibody, in Participants With Relapsed or Refractory Multiple Myeloma
PHASE1/PHASE2
Active, not recruiting
302 participants
Started: May 16, 2017 · Completed: May 28, 2027
1 condition
1 sponsor
13 locations
NCT03436238
Myocardial Injury in Noncardiac Surgery in Sweden
N/A
Active, not recruiting
1,269 participants
Started: May 15, 2017 · Completed: Dec 31, 2025
2 conditions
3 sponsors
7 locations
NCT03158064
Evaluating Immune Therapy, Duravalumab (MEDI4736) With Tremelimumab for Relapsed/Refractory Germ Cell Tumors
PHASE2
Active, not recruiting
30 participants
Started: May 15, 2017 · Completed: Nov 30, 2025
6 conditions
2 sponsors
7 locations
NCT03132922
MAGE-A4ᶜ¹º³²T for Multi-Tumor
PHASE1
Active, not recruiting
71 participants
Started: May 15, 2017 · Completed: Sep 30, 2032
10 conditions
1 sponsor
11 locations
NCT03012789
Surgical Intervention and the NETest
NA
Active, not recruiting
40 participants
Started: May 15, 2017 · Completed: Jun 30, 2026
2 conditions
1 sponsor
1 location
NCT03779269
Effect of Preksha Meditation on Cognitive Abilities and Pulmonary Function in Students
NA
Active, not recruiting
142 participants
Started: May 14, 2017 · Completed: Dec 14, 2025
2 conditions
2 sponsors
2 locations
NCT03126409
No-Touch Versus Conventional Saphenous Vein Harvesting Technique
NA
Active, not recruiting
2,655 participants
Started: May 14, 2017 · Completed: Dec 30, 2029
1 condition
1 sponsor
1 location
NCT02314481
Deciphering Antitumour Response and Resistance With INtratumour Heterogeneity
PHASE2
Active, not recruiting
50 participants
Started: May 12, 2017 · Completed: May 31, 2026
1 condition
2 sponsors
1 location
NCT04082117
Uptake of Genetic Counseling Among African American Women
NA
Active, not recruiting
960 participants
Started: May 12, 2017 · Completed: May 31, 2026
1 condition
1 sponsor
2 locations
NCT03159676
Proton-Based Stereotactic Ablative Body Radiotherapy for Prostate Cancer
N/A
Active, not recruiting
150 participants
Started: May 12, 2017 · Completed: Jun 30, 2029
1 condition
1 sponsor
1 location
NCT02738411
Influence of Intestinal Microbiota Implantation in Preterm Infants on Microbiota and Immune Orientation at 3 Years
N/A
Active, not recruiting
130 participants
Started: May 12, 2017 · Completed: Dec 30, 2024
1 condition
1 sponsor
3 locations
NCT03141359
Use of High Dose Radiation Followed by Chemotherapy and Radiation to Treat Locally Advanced NSCLC
PHASE2
Active, not recruiting
61 participants
Started: May 12, 2017 · Completed: Jul 31, 2027
3 conditions
3 sponsors
1 location
NCT03255694
A Study Extension Period of PEG-somatropin (Pegylated-somatropin) in the Treatment of Children With Idiopathic Short Stature
PHASE2
Active, not recruiting
360 participants
Started: May 12, 2017 · Completed: Jun 30, 2030
1 condition
13 sponsors
12 locations
NCT06018857
Registry 17-009: Multi-Institutional Study Examining Patients With HCC Undergoing Liver Transplantation
N/A
Active, not recruiting
1,000 participants
Started: May 11, 2017 · Completed: Dec 31, 2026
1 condition
2 sponsors
2 locations
NCT03090633
Fetoscopic Repair of Isolated Fetal Spina Bifida
NA
Active, not recruiting
30 participants
Started: May 11, 2017 · Completed: Apr 30, 2027
6 conditions
1 sponsor
1 location
NCT03055598
Ferric Citrate in ESRD Pilot Project
PHASE4
Active, not recruiting
30 participants
Started: May 11, 2017 · Completed: Feb 29, 2020
2 conditions
2 sponsors
2 locations
NCT03112980
Randomized Trial of TAVI vs. SAVR in Patients With Severe Aortic Valve Stenosis at Low to Intermediate Risk of Mortality
NA
Active, not recruiting
1,414 participants
Started: May 10, 2017 · Completed: Jan 31, 2028
1 condition
3 sponsors
43 locations
NCT03081143
Ramucirumab Plus FOLFIRI Versus Ramucirumab Plus Paclitaxel in Patients with Advanced or Metastatic Gastric Cancer, Who Failed One Prior Line of Palliative Chemotherapy
PHASE2/PHASE3
Active, not recruiting
429 participants
Started: May 10, 2017 · Completed: Dec 31, 2025
1 condition
1 sponsor
16 locations
NCT02818972
RelayPro Thoracic Stent-Graft in Subjects With Thoracic Aortic Aneurysms and Penetrating Atherosclerotic Ulcers
NA
Active, not recruiting
110 participants
Started: May 10, 2017 · Completed: Dec 31, 2025
2 conditions
1 sponsor
35 locations
NCT03520101
Comparison of the Balloon-Expandable Edwards Valve and Self-Expandable CoreValve Evolut R or Evolut PRO System for the Treatment of Small, Severely Dysfunctional Surgical Aortic Bioprotheses. The 'LYTEN' Trial
NA
Active, not recruiting
102 participants
Started: May 10, 2017 · Completed: May 31, 2024
3 conditions
1 sponsor
1 location
NCT03104439
Nivolumab and Ipilimumab and Radiation Therapy in MSS and MSI High Colorectal and Pancreatic Cancer
PHASE2
Active, not recruiting
84 participants
Started: May 10, 2017 · Completed: Apr 30, 2027
3 conditions
2 sponsors
1 location
NCT02841748
A Randomized, Double-Blind Phase II Study of Adjuvant Pembrolizumab Versus Placebo in Head and Neck Cancers at High Risk for Recurrence- the PATHWay Study
PHASE2
Active, not recruiting
100 participants
Started: May 10, 2017 · Completed: Jun 25, 2026
2 conditions
1 sponsor
4 locations
NCT03151564
Lesion Detection Assessment in the Liver: Standard vs Low Radiation Dose Using Varied Post-Processing Techniques
NA
Active, not recruiting
146 participants
Started: May 9, 2017 · Completed: Apr 30, 2027
4 conditions
1 sponsor
1 location
NCT03163368
Dose Escalation Trial of Neoadjuvant Radiosurgery for the Treatment of Metastatic Brain Tumors
EARLY_PHASE1
Active, not recruiting
25 participants
Started: May 9, 2017 · Completed: Nov 1, 2025
1 condition
1 sponsor
1 location
NCT06916715
MR Elastography in Intracranial Lesions: Feasibility & Accuracy
N/A
Active, not recruiting
512 participants
Started: May 9, 2017 · Completed: Dec 9, 2025
1 condition
1 sponsor
1 location
NCT03122717
Osimertinib and Gefitinib in EGFR Inhibitor naïve Advanced EGFR Mutant Lung Cancer
PHASE1/PHASE2
Active, not recruiting
48 participants
Started: May 9, 2017 · Completed: Oct 31, 2026
1 condition
2 sponsors
2 locations
NCT03022708
Xeltis Bioabsorbable Pulmonary Valved Conduit Pivotal Study
NA
Active, not recruiting
56 participants
Started: May 8, 2017 · Completed: Dec 31, 2026
1 condition
1 sponsor
10 locations
NCT03772977
The Brain Health Champion Study
NA
Active, not recruiting
95 participants
Started: May 8, 2017 · Completed: Jun 1, 2025
4 conditions
1 sponsor
1 location
NCT03142893
Hormonal Mechanisms of Sleep Restriction - Axis Study
PHASE1
Active, not recruiting
80 participants
Started: May 8, 2017 · Completed: Jun 30, 2026
1 condition
1 sponsor
1 location
NCT03132792
AFPᶜ³³²T in Advanced HCC
PHASE1
Active, not recruiting
45 participants
Started: May 8, 2017 · Completed: Dec 7, 2025
2 conditions
1 sponsor
21 locations
Previous
1
More pages
362
363
364
365
366
367
368
More pages
431
Next